Indeed, the NF-κB pathway is consistently upregulated upon catabolic conditions in both mouse models [89,97,98] and patients suffering from chronic obstructive pulmonary disease (COPD) [99] or chronic heart failure (CHF) [100] patients. This evidence concerns the gene NFKB1 and congestive heart failure.